The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects.

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Data from the CEPHEUS trial support the use of D-VRd in patients with transplant-ineligible or -deferred multiple myeloma who can tolerate bortezomib. Adding daratumumab (Darzalex) to bortezomib ...

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...